XML 45 R34.htm IDEA: XBRL DOCUMENT v3.19.2
Description of Business and Significant Accounting Policies - Additional Information (Detail)
€ in Millions
6 Months Ended 12 Months Ended
Jun. 30, 2019
USD ($)
Contract
Dec. 31, 2018
USD ($)
Contract
Jun. 30, 2019
EUR (€)
Jun. 30, 2018
USD ($)
Dec. 31, 2017
USD ($)
Jul. 01, 2013
USD ($)
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]            
Accumulated deficit $ (2,967,270,000) $ (2,940,000,000)        
Cash and cash equivalents and restricted cash 13,284,000 $ 71,684,000   $ 26,705,000 $ 48,355,000  
Short-term investments 24,909,000          
Principal amount of outstanding borrowings 99,200,000          
Loss on purchase commitments | €     € 82.3      
(“ASC”) Topic 842 – Leases            
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]            
Increase in total assets and total liabilities 5,200,000          
Short-term Investments            
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]            
Gain (loss) on investments 0          
Insulin            
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]            
Loss on purchase commitments $ 93,600,000          
Loss on purchase commitments, number of new contracts recognized | Contract 0 0        
Maximum | AFREZZA product sales            
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]            
Sales return right following product expiration in months 12 months          
Minimum | AFREZZA product sales            
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]            
Sales return right following product expiration in months 6 months          
Deerfield | Minimum            
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]            
Available amount of credit facility under covenant restrictions for each quarter end after current fiscal   $ 25,000,000        
Deerfield | 2019 notes            
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]            
Senior notes, effective interest rate 9.75%   9.75%      
Principal amount of outstanding borrowings           $ 160,000,000
Deerfield | Tranche B notes            
Organization Consolidation And Presentation Of Financial Statements Disclosure [Line Items]            
Senior notes, effective interest rate 8.75%   8.75%